NASDAQ Careers: Find a Job Now
Web NASDAQ.com
Search
Save my stocks for next time

Symbol List ViewsSymbol List Views

Stock DetailsStock Details

Stock DetailsCHARTS

Stock DetailsCOMPANY NEWS

Stock DetailsSTOCK ANALYSIS

Stock DetailsFUNDAMENTALS

Stock DetailsHOLDINGS

ERES: Stock Quote & Summary Data

$ 5.80 0.10 1.69%
Nov. 20, 2009 Market Closed
Update Quotes: . Updates every 7 Seconds.
eResearch Technology Inc.
ERES | eResearch Technology Inc. | Common Stock | Market : NASDAQ-GS

Last Sale
Change Net / %
Best Bid / Ask
1y Target Est: $ 7.75
Today's High / Low  / 
Share Volume
50 Day Avg. Daily Volume 352,768
Previous Close $ 5.90
52 Wk High / Low $ 8.50 / $ 3.86
Shares Outstanding 48,468,000
Market Value $ 281,114,400
P/E Ratio 22.31
Forward P/E (1yr) 19.67
Earnings Per Share $ 0.26
Annualized Dividend N/A
Ex Dividend Date N/A
Dividend Payment Date N/A
Current Yield N/A
Beta 0.66
NASDAQ Official Open Price: $ 5.85
Date of NASDAQ Official Open Price: Nov. 20, 2009
NASDAQ Official Close Price: $ 5.80
Date of NASDAQ Official Close Price: Nov. 20, 2009

 Intraday Chart

5d | 1m | 6m | 12m | More Charting

Have a Question About ERES?

Ask your question about about eResearch Technology Inc. (ERES) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!

Hot Topics in NASDAQ Answers

The most popular questions & answers in the
NASDAQ Answers Community:


 Company Description (as filed with the SEC)

eResearchTechnology, Inc. (eRT), a Delaware corporation, was founded in 1977 to provide Cardiac Safety services to evaluate the safety of new drugs. eRT and its consolidated subsidiaries collectively are referred to as the “Company” or “we.” We provide technology and services that enable the pharmaceutical, biotechnology and medical device industries to collect, interpret and distribute cardiac safety and clinical data more efficiently. We are a market leader in providing centralized electrocardiographic services (Cardiac Safety services or EXPeRT® ECG services) and a leading provider of technology and services that streamline the clinical trials process by enabling our clients to evolve from traditional, paper-based methods to electronic processing using our EXPeRT® eClinical and EXPeRT® ePRO products and services.  ... More ...  

Get ETF News, Commentary, Tools & more...

Visit the new NASDAQ.com ETFs hub Now

 Company News for ERES

Chairman Buys $6.4M Worth of Shaw Group
- TheStreet  11/05/2009 10:03AM
ERT Reports Third Quarter 2009 Results
- PR Newswire  10/29/2009 4:05PM
EResearchTechnology Q3 09 Earnings Conference Call At 5:00 PM
- RTT News  10/29/2009 2:40PM
ERT to Announce 2009 Third Quarter Results on October 29, 2009
- PR Newswire  10/21/2009 11:45AM
EResearchTechnology To Present At UBS Global Life Sciences Conference; Webcast At 11:00 AM
- RTT News  09/21/2009 10:27AM
ERT to Present at UBS Global Life Sciences Conference on September 21, 2009
- PR Newswire  09/14/2009 4:02PM
EResearchTechnology To Present At Baird''s 2009 Health Care Conference At 11:30 AM
- RTT News  09/09/2009 11:15AM